Family Clinical Trials, LLC.
Pembroke Pines, Florida 33026
0 studies enrolling now · 6 studies all time
What they study most
COVID-19, Refractory Chronic Gout, Rheumatoid Arthritis
Studies at this site
- Study of Obeldesivir in Nonhospitalized Participants With COVID-19 — Completed
- Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis — Completed
- Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease — Completed
- Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease — Completed
- Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout — Completed
- Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis — Completed